| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |